Alpha Wave Global’s Faeth Therapeutics FTH Stock Holding History

Alpha Wave Global’s Portfolio FTH Stock Details FTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,683	Closed	-$3.1M	–	114
2021 Q1	$3.1M	Buy	+10,683	New	+$3.58M	0.19%	64

Other funds holding FTH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpha Wave Global's FTH Position: Q2 2021 in Review

Alpha Wave Global sold out of Faeth Therapeutics (FTH) in Q2 2021, closing a stake of 10,683 shares — an estimated $3.1M sold.

Alpha Wave Global first reported a position in FTH in Q1 2021 and held it in 1 quarter. The position peaked at $3.1M in Q1 2021. 34 funds tracked by Wall St. Rank hold FTH as of Q2 2021.

Alpha Wave Global reported no remaining Faeth Therapeutics position as of Q2 2021 after selling out during the quarter.
Alpha Wave Global sold 10,683 Faeth Therapeutics shares in Q2 2021, an estimated $3.1M.
Alpha Wave Global first reported a position in Faeth Therapeutics in Q1 2021 and held it in 1 quarter.
Alpha Wave Global's Faeth Therapeutics position peaked at $3.1M in Q1 2021.
34 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2021.

Based on Alpha Wave Global's 13F filing for Q2 2021, filed 13 Aug 2021.